(Note: Fogo Hospitality Inc. withdrew its IPO registration in a letter to the SEC, a March 19, 2024, filing shows. The Brazilian steakhouse chain agreed to be acquired by Bain Capital last summer. Fogo Hospitality filed its S-1 on Nov. 16, 2021.) We are Fogo de Chão (fogo-dee-shoun), an internationally renowned, growing restaurant brand. For more than […]

We are a blank check company. It is our intention to pursue prospective targets that are in the technology, Internet and consumer sectors. We will look for companies with established brands, stable cash flow and readiness to access capital markets. In addition, we want to find companies that are truly technology driven and have strong […]

We are a blank-check company focused on the renewable energy industry in OECD countries. (Incorporated in the Cayman Islands) (Note: ClimateRock Acquisition Corp. priced its SPAC IPO on April 27, 2022, in sync with the terms in its prospectus: 7.5 million units at $10 each to raise $75 million. ClimateRock became the 60th SPAC IPO […]

We intend to capitalize on the deep expertise, experience and network of our management team and our board of directors to effect a successful business combination, with a focus on opportunities in the global energy transition ecosystem. (Incorporated in the Cayman Islands) Our sponsor is an affiliate of Denham Capital Management LP, a private equity […]

(Note: JE Cleantech Holdings Limited priced its IPO on April 21, 2022, by selling 3.75 million shares, the same number as in the prospectus, at $4 each – the expected IPO price – to raise $15 million. Of the 3.75 million shares sold: The company offered 3.0 million shares and the other 750,000 shares came […]

We intend to focus on businesses in Asia (excluding China, Hong Kong and Macau) with enterprise values between $200 million and $600 million. (Incorporated in the Cayman Islands) (Note: TenX Keane Acquisition priced its SPAC IPO on Oct. 13, 2022, in line with the terms in its prospectus: 6.0 million units at $10.00 each to […]

We are a clinical-stage biotechnology company focused on developing natural killer (NK) cell-based therapies for patients suffering from devastating autoimmune diseases and cancers. (Incorporated in Delaware) Our product candidates are derived from donor cells (allogeneic) rather than a patient’s own cells (autologous) and are pre-manufactured, stored frozen and ready to ship to a patient’s treatment […]

(Note: This is NOT an IPO. This is a NASDAQ uplisting from the Tel Aviv Stock Exchange. IPOScoop has NO CALL on uplistings. This public offering/uplisting is a unit offering with proposed symbol “SVRE” for the stock and proposed symbol “SVREW” for the warrant. Each unit consists of one American Depositary Share (ADS) and one […]

(Note: This is an IPO unit offering. IPOScoop has NO CALL on unit IPOs. Locafy Limited is offering 1.82 million units – up to $10 million in estimated IPO proceeds – at an IPO price expected to be between $4.50 and $6.50 per unit, according to its F-1/A filing dated March 7, 2022. The assumed […]

We are a clinical stage biotechnology company developing novel immune therapeutics for the prevention, treatment and mitigation of bacterial, fungal and parasitic infections that express the antigenic target poly N-acetyl glucosamine (PNAG). That target has been found on an expanding number of pathogens. While the ultimate decision on the safety and efficacy of our therapeutics […]